Fig. 2From: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injuryConsort diagram for PRISM II cohort. CNS-LS = center for neurologic study–lability scaleBack to article page